Study Evaluating Two Loading Regimens of Sunitinib Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: 12.5mg sunitinib with Cisplatin and Gemcitabine;   Drug: 25mg Sunitinib alternating with Cisplatin and Gemcitabine
Sponsor:   National University Hospital, Singapore
Recruiting - verified June 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/28WrJ03
via IFTTT